InnoCare Pharma has been granted a patent for various crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide, along with related pharmaceutical compositions. The crystalline form specified in the claim exhibits distinct X-ray diffraction peaks at specific angles. GlobalData’s report on InnoCare Pharma gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on InnoCare Pharma, Cancer treatment biomarkers was a key innovation area identified from patents. InnoCare Pharma's grant share as of May 2024 was 29%. Grant share is based on the ratio of number of grants to total number of patents.
Patent granted for crystalline form of specific chemical compound
A recently granted patent (Publication Number: US11945792B2) discloses a series of crystalline forms of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide, each characterized by specific X-ray diffraction peaks and intensities. These forms exhibit distinct peaks at various degrees 2?, with the most intense peak varying depending on the specific crystalline form. For example, one form has peaks at 5.4°±0.2°, 8.4°±0.2°, 18.7°±0.2°, 19.1°±0.2°, 16.1°±0.2°, 21.9°±0.2°, and 10.1°±0.2° degrees 2?, with the most intense peak at 5.4±0.2 degrees 2?.
Furthermore, the patent includes a claim for a pharmaceutical composition comprising any of the aforementioned crystalline forms (1-5) of 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide along with a pharmaceutically acceptable carrier. This composition combines the unique crystalline structures with a carrier to potentially enhance the drug's stability, bioavailability, or other pharmaceutical properties. The patent's focus on specific crystalline forms and their incorporation into pharmaceutical compositions highlights the importance of crystal engineering in drug development and formulation processes.
To know more about GlobalData’s detailed insights on InnoCare Pharma, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
